CBZ may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In 28 of 34 cases where CBZ's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are 82%.
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where CBZ's RSI Oscillator exited the oversold zone, of 21 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .
The Momentum Indicator moved above the 0 level on June 30, 2022. You may want to consider a long position or call options on CBZ as a result. In of 87 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .
The Moving Average Convergence Divergence (MACD) for CBZ just turned positive on June 29, 2022. Looking at past instances where CBZ's MACD turned positive, the stock continued to rise in of 41 cases over the following month. The odds of a continued upward trend are .
CBZ moved above its 50-day moving average on July 01, 2022 date and that indicates a change from a downward trend to an upward trend.
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where CBZ advanced for three days, in of 336 cases, the price rose further within the following month. The odds of a continued upward trend are .
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 3 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
The 10-day moving average for CBZ crossed bearishly below the 50-day moving average on June 16, 2022. This indicates that the trend has shifted lower and could be considered a sell signal. In of 16 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CBZ declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
The Aroon Indicator for CBZ entered a downward trend on May 31, 2022. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 83, placing this stock better than average.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. CBZ’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.783) is normal, around the industry mean (24.556). P/E Ratio (27.027) is within average values for comparable stocks, (57.804). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (3.090). Dividend Yield (0.000) settles around the average of (0.034) among similar stocks. P/S Ratio (1.810) is also within normal values, averaging (48.278).
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a provider of financial and employee benefits services
|MFs / NAME||Price $||Chg $||Chg %|
|ClearBridge Tactical Dividend Income I|
|American Funds Invmt Co of Amer R2|
|Cohen & Steers Alternative Inc R|
|T. Rowe Price European Stock|
|Permanent Portfolio Permanent C|
A.I.dvisor indicates that over the last year, CBZ has been loosely correlated with BRC. These tickers have moved in lockstep 62% of the time. This A.I.-generated data suggests there is some statistical probability that if CBZ jumps, then BRC could also see price increases.
|BRC - CBZ|
|FORR - CBZ|
|ICFI - CBZ|
|MSA - CBZ|
|EXPO - CBZ|